Watch Webinar Recording
  • 24 March 2020
  • Duration: 50 min
6 Symptoms of Disease:
Risks for Online Pharmaceutical Market

In no other industry does the distribution of counterfeit products harm customers as much as in the pharmaceutical industry. Pharma brands must take proactive steps to stay ahead of criminals who counterfeit their drugs. Protection against the online distribution of suspicious medicinal products can be crucial. To look into the illegal use of pharma brands, Group-IB’s Digital Risk Protection team analyzed online sales of seven of the most common drugs produced by various manufacturers.

Join our webinar and listen to the discussion that unveils the investigation's main findings:

  • Most often, fraudulent resources are disguised as websites belonging to ordinary pharmacies.
  • Fraudsters sometimes buy dozens of domain names purporting to be those of a single pharmaceutical company.
  • Bulletin boards can contain up to 2,500 offers per drug.

Contact us +65 3159–3798 or

Contact us +65 3159–3798 or


Anton Dolgalev

Head of Digital Risk Protection Team

Igor Stolyarov

Lead Sales Manager

Group-IB is one of the leading providers of solutions aimed at detection and prevention of cyberattacks, online fraud, and IP protection. Group-IB Threat Intelligence & Attribution system was named one of the best in class by Gartner, Forrester, and IDC.

Group-IB’s technological leadership is built on the company’s 18 years of experience in cybercrime investigations worldwide and 70,000 hours of incident response accumulated in our leading forensic laboratory and 24/7 CERT-GIB.

Group-IB actively collaborates with international partners such as INTERPOL and Europol in the fight against cybercrime, and is an industry-leading cybersecurity solutions provider.

Learn more

Get new report
Ransomware Uncovered 2021/2022

The well-known complete guide to the latest tactics, techniques, and procedures of ransomware operators based on MITRE ATT&CK®

Report an incident

Get 24/7 incident response assistance from our global team

APAC: +65 3159-3798
Europe: +31 20 226-90-90
EMA: +971 4 508 1605

Thank you for filling out the form! We will get back to you shortly.

We use cookies on the website to make your browser experience more personal, convenient and secure. You may block or manage the use of cookies, however, in some cases they’re essential to make this site work properly. Learn more about cookies in Group-IB Privacy And Cookies Policy.

Get new report Ransomware Uncovered 2021/2022